Oncothyreon Announces Third Quarter 2013 Financial Results Conference Call
SEATTLE, Nov. 4, 2013
SEATTLE, Nov. 4, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today
announced that it will conduct a conference call on Tuesday, November 12, 2013
at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss its third quarter
2013 financial results and provide a review of its pipeline of products in
To participate in the call by telephone, please dial (877) 280-7291 (United
States) or (707) 287-9361 (International). In addition, the call will be
webcast live and can be accessed on the "Events" page of the "News & Events"
section of Oncothyreon's website at www.oncothyreon.com. An archive of the
webcast will be available after completion of the discussion and will be
posted on the Oncothyreon website.
Oncothyreon is a biotechnology company specializing in the development of
innovative therapeutic products for the treatment of cancer. Oncothyreon's
goal is to develop and commercialize novel synthetic vaccines and targeted
small molecules that have the potential to improve the lives and outcomes of
cancer patients. For more information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
Investor and Media Relations Contact:
2601 Fourth Avenue, Suite 500
Seattle, WA 98121
Tel: (206) 801-2100
Fax: (206) 801-2101
Press spacebar to pause and continue. Press esc to stop.